Belzutifan - HY-125840
Nur noch %1 verfügbar
Catalog #
HY-125840
Ab
196,00 €
Belzutifan (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of 9 nM. Belzutifan, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. Belzutifan is a potential treatment for clear cell renal cell carcinoma (ccRCC)[1].
Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-125840/Belzutifan-DataSheet-MedChemExpress.pdf |
---|---|
Shipping | Blue Ice |
Application | Cancer-programmed cell death |
Alternative Names | PT2977; MK-6482 |
CAS | 1672668-24-4 |
Storage | -20°C (Powder, stored under nitrogen) |
MWT | 383.34 |
Solubility | Acetone : 50 mg/mL (ultrasonic)|DMSO : 50 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) |
Clinical Information | Launched |
Target | HIF/HIF Prolyl-Hydroxylase |
Application: | Cancer-programmed cell death |
---|